The economic profile of peginterferon beta-1a in the treatment of relapsing-remitting multiple sclerosis in Italy
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s40893-017-0030-6
Published Online: 2017-08-21
Published Print: 2017-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Centonze, Diego
Iannazzo, Sergio
Santoni, Laura
Saleri, Cecilia
Puma, Elisa
Giuliani, Luigi
Canonico, Pier Luigi